Nur et al. [39] assessed 83 volunteers (60 patients with lung cancer and 23 healthy individuals) and found that the serum concentration of IGFBP4 was a better predictor of lung cancer than serum concentrations of PAPP-A. Here, IGFBP4 is linked to lung cancer.